Effectiveness analysis of herbal medicine for gastroesophageal reflux disease: A retrospective study
- PMID: 38394512
- PMCID: PMC10883622
- DOI: 10.1097/MD.0000000000037295
Effectiveness analysis of herbal medicine for gastroesophageal reflux disease: A retrospective study
Abstract
This study aimed to identify the clinical features of gastroesophageal reflux disease (GERD) in primary clinics and the effectiveness and safety of herbal medicine (HM). Thirty-five patients with gastroesophageal-reflux symptom who visited the 16 Korean medicine (KM) primary clinics from June 2022 to October 2022 were included in the study. We retrospectively analyzed the charts of 35 patients and collected clinical characteristics, HM, and outcome variables such as the numerical rating scale, gastroesophageal reflux disease questionnaire, frequency scale for symptoms of gastroesophageal reflux disease, Euro-Quality Of Life-5 Dimension, and adverse events. Of the 35 patients, 12 (34.3%) were men, and the average age of all patients was 47.0 ± 14.3 years. HM was prescribed for all 35 patients; Pinelliae Tuber (n = 31, 88.57%), Zingiberis Rhizoma Recens (n = 30, 85.71%), and Poria Sclerotium (n = 28, 80%) were the most prescribed herbs. All scores including numerical rating scale, frequency scale for symptoms of gastroesophageal reflux disease, gastroesophageal reflux disease questionnaire, and Euro-Quality Of Life-5 Dimension after 30 and 60 days from baselines showed significant improvement, and there were only a few adverse events. This study supports the effectiveness and safety of HM in reducing GERD symptoms in primary Korean medicine clinics. The most frequently used herbs may play significant roles in GERD symptom management.
Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures


Similar articles
-
Efficacy and safety of Ojeok-san plus Saengmaek-san for gastroesophageal reflux-induced chronic cough: protocol for a pilot, randomized, double-blind, placebo-controlled trial.Trials. 2020 Jan 29;21(1):118. doi: 10.1186/s13063-019-4030-z. Trials. 2020. PMID: 31996267 Free PMC article.
-
Prevalence of gastroesophageal reflux disease symptoms and effects of esomeprazole on the quality of life related to reflux and dyspepsia in patients on maintenance hemodialysis.Clin Exp Nephrol. 2016 Feb;20(1):134-42. doi: 10.1007/s10157-015-1130-2. Epub 2015 May 31. Clin Exp Nephrol. 2016. PMID: 26026991
-
How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?World J Gastroenterol. 2012 Aug 28;18(32):4363-70. doi: 10.3748/wjg.v18.i32.4363. World J Gastroenterol. 2012. PMID: 22969200 Free PMC article.
-
Medicinal Plants for Management of Gastroesophageal Reflux Disease: A Review of Animal and Human Studies.J Altern Complement Med. 2017 Feb;23(2):82-95. doi: 10.1089/acm.2016.0233. Epub 2016 Dec 20. J Altern Complement Med. 2017. PMID: 27996295 Review.
-
Look--but also listen! ReQuest: an essay on a new validated scale to assess the outcome of GERD treatment.Digestion. 2007;75 Suppl 1:87-100. doi: 10.1159/000101020. Epub 2007 May 4. Digestion. 2007. PMID: 17489037 Review.
References
-
- Vakil N, van Zanten SV, Kahrilas P, et al. . The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–20; quiz 1943. - PubMed
-
- Available at: https://www.hira.or.kr/bbsDummy.do?pgmid=HIRAA020045030000.
-
- Lee YC. Management of refractory GERD. Korean J Med. 2010;78:301–8.
-
- Haastrup PF, Thompson W, Søndergaard J, et al. . Side effects of long-term proton pump inhibitor use: a review. Basic Clin Pharmacol Toxicol. 2018;123:114–21. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical